VEGF Levels in Premenopausal Women and Breast Cancer Surgery Timing
Author Information
Author(s): K Heerl, H Kumar, V Speirs, J Greenman, PJ Drew, JN Fox, PJ Carleton, JRT Monson, MJ Kerin
Primary Institution: University of Hull
Hypothesis
Can the study of VEGF in relation to the menstrual cycle help determine the best timing for breast cancer surgery in premenopausal women?
Conclusion
Serum VEGF levels are significantly lower in the luteal phase of the menstrual cycle, suggesting a decreased potential for micrometastasis establishment during this phase.
Supporting Evidence
- VEGF levels were significantly lower in the luteal phase compared to the follicular phase.
- A significant negative correlation was found between VEGF and progesterone levels.
- The average fall in VEGF levels between the two phases was 53.2%.
- Previous studies have suggested better survival rates for surgeries performed in the luteal phase.
Takeaway
This study found that a substance called VEGF, which helps tumors grow, is lower in women during a certain time of their monthly cycle, which might be a better time for breast cancer surgery.
Methodology
Blood samples were taken from 14 premenopausal women at 4-day intervals over one menstrual cycle and analyzed for sex hormones and VEGF165.
Potential Biases
Potential bias due to the small number of participants and the specific demographic of the study group.
Limitations
The study had a small sample size and included only a specific population of premenopausal women.
Participant Demographics
14 premenopausal women with no prior history of breast disorders, along with control groups of post-menopausal women and one male subject.
Statistical Information
P-Value
0.03
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website